Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Lack of engagement with psychological therapies
Lamotrigine borderline personality disorder in overdose restarting after period of non-compliance clozapine augmentation life-threatening cutaneous reactions target range
Laxative misuse/abuse Biochemical and haematological effects of psychotropics Eating disorders
Laxatives Acting on clozapine plasma concentration results Clozapine-induced gastrointestinal hypomotility Safer prescribing for physical conditions in dementia Clozapine: common adverse effects Initiation of clozapine in the community
Learning difficulties epilepsy comorbidity Learning disabilities capacity and consent general considerations prescribing practice
Legal issues
Lemborexant managing sleep disturbance in dementia in overdose use in patients with hepatic impairment
Less commonly used treatments, well supported by published evidence (no preference implied by order)
Levetiracetam, for tardive dyskinesia
Levomepromazine Relative adverse effects - a rough guide Quick reference for licensed maximum doses
Lewy body dementia Parkinson's disease Dementia
Licensed maximum doses of antipsychotics, according to US Food and Drug Administration labelling, where available
Linear dose reductions of olanzapine cause increasingly large reductions in D2 dopaminergic receptor blockade.
Linear reductions of dose cause increasingly large reductions in effect on receptor targets, probably associated with more withdrawal effects.
Liraglutide, for antipsychotic-induced weight gain
Lisdexamfetamine borderline personality disorder attention deficit hyperactivity disorder in adults bulimia nervosa/binge eating disorder
Lithium: clinically relevant drug interactions
Lithium plasma levels
Lithium
liver function tests (LFTs) monitoring to access drug effects interpretation
Lofexidine, clozapine-induced hypersalivation
long-acting injectable (LAI)
Long-acting oral antipsychotics improving adherence restarting after period of non-compliance preventing sudden cessation
Loperamide, safety in older patients/dementia
Lactate in blood, psychotropic agent effects
Leukopenia, psychotropic agent effects
Libido
Linaclotide, for constipation treatment
Linear reductions of dose cause increasingly large reductions in effect on GABA-A receptor occupancy.
Lipoproteins in blood, psychotropic agent effects